Found: 4
Select item for more details and to access through your institution.
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1327, doi. 10.3390/cancers14051327
- By:
- Publication type:
- Article
Immune dysregulation in cancer patients developing immune-related adverse events.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A "Two‐Hit" Autoimmune Toxicity or Clinical Predisposition?
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1242, doi. 10.1634/theoncologist.2019-0911
- By:
- Publication type:
- Article
Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e753, doi. 10.1634/theoncologist.2019-0666
- By:
- Publication type:
- Article